Increased use of antipsychotic long-acting injections with community treatment orders

Therapeutic Advances in Psychopharmacology

Volumn 1, Issue 2, 2011, Pages 37-45

  Patel, Maxine X ^a   Matonhodze, Jane ^b   Baig, Mirza K ^b   Gilleen, James ^a   Boydell, Jane ^a   Holloway, Frank ^b   Taylor, David ^b   Szmukler, George ^a   Lambert, Tim ^c   David, Anthony S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

antipsychotic agents; community treatment order; delayed action preparations; ethnicity; legislation; schizophrenia

Indexed keywords

ANTIPSYCHOTIC LONG ACTING INJECTION; ATYPICAL ANTIPSYCHOTIC AGENT; FLUPENTIXOL DECANOATE; PIPOTIAZINE PALMITATE; PSYCHOTROPIC AGENT; RISPERIDONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CERTIFICATION; COHORT ANALYSIS; COMMUNITY TREATMENT ORDER; CONTROLLED STUDY; DRUG UTILIZATION; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL VARIATION (SPECIES); GROUP THERAPY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; LAW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLING; SCHIZOPHRENIA; SECOND OPINION APPOINTED DOCTOR;

EID: 84997943783     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125311407960     Document Type: Article

References (47)

1. Audini B. Lelliott P. (2002) Age, gender and ethnicity of those detained under Part II of the Mental Health Act 1983. Br J Psychiat 180: 222–226.
2. Barnes T.R.E. Shingleton-Smith A. Paton C. (2009) Antipsychotic long-acting injections: prescribing practice in the UK. Br J Psychiat 95(Suppl. 52): s37–s42.
3. Bhui K. Stansfeld S. Hull S. Priebe S. Mole F. Feder G. (2003) Ethnic variations in pathways to and use of specialist mental health services in the UK. Systematic review. Br J Psychiat 182: 105–116.
4. Brookes G. Brindle N. (2010) Compulsion in the community? The introduction of supervised community treatment. Adv Psych Treat 16: 242–252.
5. Burnett R. Mallett R. Bhugra D. Hutchinson G. Der G. Leff J. (1999) The first contact of patients with schizophrenia with psychiatric services: social factors and pathways to care in a multi-ethnic population. Psychol Med 29: 475–483.
6. Burns T. Dawson J. (2009) Community treatment orders: How ethical without experimental evidence? Psychol Med 39: 1583–1586.
7. Burns T. Rugkasa J. Molodynski A. (2008) The Oxford community treatment order trial (OCTET). Psychiatr Bull 32: 400–400.
8. Care Quality Commission (2009) ‘Count me in’ census 2009 report. http://www.cqc.org.uk/guidanceforprofessionals/mentalhealth/countmeincensus/countmeincensus2009.cfm (accessed 10 March 2011).
9. Care Quality Commission (2010) Mental Health Act 1983 and Mental Capacity Act 2005. Short Paper for Board Meeting 11 November 2010, http://www.cqc.org.uk/_db/_documents/20100211_CM100104_MHA_and_MCA_Cover_paper_Final.doc (accessed 10 March 2011).
10. Chen E.Y. Harrison G. Standen P.J. (1991) Management of first episode psychotic illness in Afro-Caribbean patients. Br J Psychiat 1585: 517–522.
11. Churchill R. Owen D. Singh S. Hotopf M. (2007) International Experiences of Using Community Treatment Orders, London: Department of Health.
12. Connolly A. Taylor D. (2008) Ethnicity and quality of antipsychotic prescribing among inpatients in South London. Br J Psychiat 193: 161–162.
13. Department of Health (2007) Mental Health Act 2007, http://www.opsi.gov.uk/acts/acts2007/pdf/ukpga_20070012_en.pdf (accessed 10 March 2011).
14. Department of Health (2008) Code of Practice – Mental Health Act 1983, http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_087073.pdf (accessed 10 March 2011).
15. Eaton L. (2010) Two thirds of psychiatric patients are treated on mixed sex wards, show census. BMJ 340: c451–c451.
16. Evans R. Makala J. Humphreys M. Mohan R.N. (2010) Supervised community treatment – The first six months in Birmingham and Solihull. The Psychiatrist 34: 330–333.
17. Fearon P. Kirkbride J.B. Morgan C. Dazzan P. Morgan K. Lloyd T. et al. (2006) Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP study. Psychol Med 36: 1541–1550.
18. Gould, M. (2009) Hazards of a health safeguard. The Guardian, 13 May 2009, http://www.guardian.co.uk/society/2009/may/13/supervised-community-treatment-order (accessed 10 March 2011).
19. Kisely S. Campbell L.A. Preston N. (2005) Compulsory community and involuntary outpatient treatment for people with severe mental disorders. Cochrane Database Syst Rev, CD004408.
20. Lambert T.J. Singh B.S. Patel M.X. (2009) Community treatment orders and antipsychotic long-acting injections. Br J Psychiat 95(Suppl. 52): s57–s62.
21. Langan J. Shajahan P. (2010) Antipsychotic polypharmacy: review of mechanisms, mortality and management. The Psychiatrist 34: 58–62.
22. Leucht C. Heres S. Kane J.M. Kissling W. Davis J.M. Leucht S. (2011) Oral versus depot antipsychotic drugs for schizophrenia – A critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res 127: 82–92.
23. Lloyd K. Moodley P. (1992) Psychotropic medication and ethnicity: an inpatient survey. Soc Psychiatry Psychiatr Epidemiol 27: 95–101.
24. Macpherson R. Molodynski A. Freeth R. Uppal A. Steer H. Buckle D. et al. (2010) Supervised community treatment: guidance for clinicians. Adv Psych Treat 16: 253–259.
25. McKenzie K. Bhui K. (2007) Institutional racism in mental health care. BMJ 334: 649–650.
26. Morgan C. Fearon P. Hutchinson G. McKenzie K. Lappin J.M. Abdul-Al R. et al. (2006) Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study. Psychol Med 36: 239–247.
27. Morgan C. Mallett R. Hutchinson G. Bagalkote H. Morgan K. Fearon P. et al. (2005) Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study. Br J Psychiat 186: 281–289.
28. National Institute for Clinical Excellence (2009) Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. Clinical Guidelines CG82. http://www.nice.org.uk/nicemedia/pdf/CG82NICEGuideline.pdf (accessed 10 March 2011).
29. Office for National Statistics (2001) 2001 Census: Census Area Statistics—Ethnic Group (UV09) Data. http://neighbourhood.statistics.gov.uk/dissemination (accessed 17 March 2010).
30. O'Reilly R. Bishop J. (2001) Assessing the New York City involuntary outpatient treatment program. Psychiatr Serv 52: 1533–1534.
31. Patel M. David A. (2005) Why aren't depot antipsychotics prescribed more often and what can be done about it? Adv Psych Treat 11: 203–213.
32. Patel M.X. Taylor M. David A.S. (2009) Antipsychotic long-acting injections: mind the gap. Br J Psychiat 95(Suppl. 52): s1–s4.
33. Paton C. Barnes T.R.E. Cavanagh M.-R. Taylor D. on behalf of the POMH-UK project team (2008) High-dose and combination antipsychotic prescribing in acute adult wards in the UK; the challenges posed by PRN. Br J Psychiat 192: 435–439.
34. Ray W.A. Chung C.P. Murray K.T. Hall K. Stein M. (2009) Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360: 225–235.
35. Rosenheck R.A. Krystal J.H. Lew R. Barnett P.G. Fiore L. Valley D. et al. (2011) Long-acting risperidone and oral antipsychotics in unstable schizophrenia. N Engl J Med 364: 842–851.
36. Royal Pharmaceutical Society of Great Britain (2008) British National Formulary, London: Royal Pharmaceutical Society of Great Britain.
37. Shi L. Ascher-Svanum H. Zhu B. Faries D. Montgomery W. Marder S.R. (2007) Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatr Serv 58: 482–488.
38. Steadman H.J. Gounis K. Dennis D. Hopper K. Roche B. Swartz M. et al. (2001) Assessing the New York City involuntary outpatient commitment pilot program. Psychiatr Serv 52: 330–336.
39. Swartz M.S. Swanson J.W. (2004) Involuntary outpatient commitment, community treatment orders, and assisted outpatient treatment: what's in the data? Can J Psychiat 49: 585–591.
40. Swartz M.S. Swanson J.W. Wagner H.R. Burns B.J. Hiday V.A. Borum R. (1999) Can involuntary outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with severely mentally ill individuals. Am J Psychiat 156: 1968–1975.
41. Szmukler G. Hotopf M. (2001) Effectiveness of involuntary outpatient commitment. Am J Psychiat 158: 653–654.
42. Taylor D. (2010a) Antipsychotic polypharmacy – confusion reigns. The Psychiatrist 34: 41–43.
43. Taylor M. (2010b) Community treatment orders and their use in the UK. Adv Psych Treat 16: 260–262.
44. Tiihonen J. Haukka J. Taylor M. Haddad P.M. Patel M.X. Korhonen P. (2011) A nationwide cohort study of oral and depot antipsychotics after first hospitalisation for schizophrenia. Am J Psychiat, in press, DOI:10.1176/appi.ajp.2011.10081224.
45. Tungaraza T.E. Gupta S. Jones J. Poole R. Slegg G. (2010) Polypharmacy and high-dose antipsychotic regimes in the community. The Psychiatrist 34: 44–46.
46. Valenstein M. Copeland L.A. Owen R. Blow F.C. Visnic S. (2001) Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J Clin Psychiat 62: 545–551.
47. World Health Organization (1992) The International Classification of Diseases, version 10 Classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines (ICD-10), Geneva: WHO.